Systematic review with meta-analysis: comparative risk of lymphoma with anti-tumour necrosis factor agents and/or thiopurines in patients with inflammatory bowel disease.
Antoine ChupinVittorio PerducaAntoine MeyerChristophe BellangerFranck CarbonnelCatherine DongPublished in: Alimentary pharmacology & therapeutics (2020)
There is an increased risk of lymphoma in IBD patients treated with anti-TNF agents, either alone or when combined with thiopurines.